Study Summary
This trial investigates the safety and effectiveness of a medical insert in children who have had eye surgery or laser treatment while under anesthesia.
- Retinal Telangiectasia
- Vitreoretinopathy
- Exudative Retinopathy
- Lattice Degeneration
- Retinal Hole
- Sickle Cell Disease
- Rhegmatogenous Retinal Detachment
- Retinal Detachment Exudative
- Retinal Detachment
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 12 Secondary · Reporting Duration: up to Day 45 post-op
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control Arm
1 of 2
Treatment Arm
1 of 2
Active Control
Experimental Treatment
30 Total Participants · 2 Treatment Groups
Primary Treatment: Treatment Arm · No Placebo Group · Phase < 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 3 - 17 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are they accepting participants below the age of fifty-five for this trial?
"For this research, our team is recruiting participants between the ages of three and seventeen." - Anonymous Online Contributor
Who is eligible to take part in this experiment?
"This medical study seeks 30 participants aged between 3 and 17 that suffer from retinal telangiectasis. To be eligible, applicants must demonstrate Familial Exudative Vitreoretinopathy, Exudative Retinopathy, Lattice degeneration, Retinal holes, Sickler's syndrome, Retinal detachment (rhegmatogenous or exudative/tractional), Procedures or Coats' Disease." - Anonymous Online Contributor
Are there vacancies for participants in this test?
"According to information facilitated by clinicaltrials.gov, this research study is not currently enrolling participants. This trial was initially posted on November 1st 2022 and last edited on the 10th of that same month. Despite this, there are 41 other studies recruiting patients at the moment." - Anonymous Online Contributor